Investment Analysts’ Updated EPS Estimates for April 14th (ABDP, AJB, ALK, AMZN, ANVS, ASPI, BP, CLLS, CNMD, CVRX)

Investment Analysts’ updated eps estimates for Tuesday, April 14th:

AB Dynamics (LON:ABDP) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 1,370 target price on the stock.

AJ Bell (LON:AJB) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a GBX 625 target price on the stock.

Alaska Air Group (NYSE:ALK) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating.

Amazon.com (NASDAQ:AMZN) had its buy rating reissued by analysts at The Goldman Sachs Group, Inc..

Annovis Bio (NYSE:ANVS) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a $17.00 target price on the stock.

ASP Isotopes (NASDAQ:ASPI) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a $11.00 target price on the stock.

BP (LON:BP) had its buy rating reissued by analysts at Barclays PLC.

BP (LON:BP) had its neutral rating reiterated by analysts at Jefferies Financial Group Inc..

BP (LON:BP) had its neutral rating reiterated by analysts at JPMorgan Chase & Co..

Cellectis (NASDAQ:CLLS) had its market outperform rating reissued by analysts at Citizens Jmp. Citizens Jmp currently has a $8.00 target price on the stock.

CONMED (NYSE:CNMD) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

CVRx (NASDAQ:CVRX) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a $10.00 price target on the stock.

GrafTech International (NYSE:EAF) had its underweight rating reissued by analysts at JPMorgan Chase & Co..

Eastman Chemical (NYSE:EMN) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. JPMorgan Chase & Co. currently has $80.00 price target on the stock, up from their previous price target of $70.00.

Escalade (NASDAQ:ESCA) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Ford Motor (NYSE:F) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. The firm currently has $15.00 target price on the stock.

FB Financial (NYSE:FBK) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $66.00 price target on the stock.

FedEx (NYSE:FDX) had its overweight rating reissued by analysts at Stephens. The firm currently has a $435.00 price target on the stock.

GFL Environmental (NYSE:GFL) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. They currently have $42.00 target price on the stock, down from their previous target price of $49.00.

Galaxy Digital (NASDAQ:GLXY) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $50.00 target price on the stock.

Greggs (LON:GRG) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 1,610 target price on the stock.

GSK (LON:GSK) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 2,500 price target on the stock.

Robinhood Markets (NASDAQ:HOOD) had its outperform rating reaffirmed by analysts at Sanford C. Bernstein. Sanford C. Bernstein currently has a $130.00 target price on the stock.

New Horizon Aircraft (NASDAQ:HOVR) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $11.00 price target on the stock.

HSBC (NYSE:HSBC) was downgraded by analysts at BNP Paribas Exane from an outperform rating to a neutral rating.

Immunocore (NASDAQ:IMCR) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $100.00 target price on the stock.

IPG Photonics (NASDAQ:IPGP) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

JPMorgan Chase & Co. (NYSE:JPM) had its buy rating reaffirmed by analysts at Barclays PLC.

Kingfisher (LON:KGF) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 303 price target on the stock.

Microbot Medical (NASDAQ:MBOT) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $12.00 price target on the stock.

MongoDB (NASDAQ:MDB) had its buy rating reiterated by analysts at Guggenheim. They currently have a $475.00 target price on the stock.

Michelin (OTCMKTS:MGDDY) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating.

Netflix (NASDAQ:NFLX) had its buy rating reaffirmed by analysts at Guggenheim. They currently have a $130.00 price target on the stock.

Norsk Hydro ASA (OTCMKTS:NHYDY) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a buy rating to a hold rating.

Omega Healthcare Investors (NYSE:OHI) had its underperform rating reaffirmed by analysts at Bank of America Corporation. They currently have a $46.00 target price on the stock, down from their previous target price of $52.00.

PageGroup (LON:PAGE) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 145 price target on the stock.

Praxis Precision Medicines (NASDAQ:PRAX) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $510.00 price target on the stock.

Rapid7 (NASDAQ:RPD) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Revolution Medicines (NASDAQ:RVMD) had its outperform rating reiterated by analysts at Wedbush.

Septerna (NASDAQ:SEPN) had its buy rating reissued by analysts at HC Wainwright. They currently have a $40.00 price target on the stock.

Somnigroup International (NYSE:SGI) had its equal weight rating reiterated by analysts at Stephens. The firm currently has a $89.00 target price on the stock.

Sirius Real Estate (LON:SRE) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 114 price target on the stock.

Stryker (NYSE:SYK) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $397.00 price target on the stock.

Theravance Biopharma (NASDAQ:TBPH) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Travere Therapeutics (NASDAQ:TVTX) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $47.00 price target on the stock.

Travere Therapeutics (NASDAQ:TVTX) was upgraded by analysts at Piper Sandler from a neutral rating to an overweight rating. They currently have $49.00 target price on the stock.

TWFG (NASDAQ:TWFG) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.